The epigenetics of autoimmunity

Francesca Meda, Marco Folci, Andrea Baccarelli, Carlo Selmi

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

The etiology of autoimmune diseases remains largely unknown. Concordance rates in monozygotic twins are lower than 50% while genome-wide association studies propose numerous significant associations representing only a minority of patients. These lines of evidence strongly support other complementary mechanisms involved in the regulation of genes expression ultimately causing overt autoimmunity. Alterations in the post-translational modification of histones and DNA methylation are the two major epigenetic mechanisms that may potentially cause a breakdown of immune tolerance and the perpetuation of autoimmune diseases. In recent years, several studies both in clinical settings and experimental models proposed that the epigenome may hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically, data support the impact of epigenetic changes in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis and other autoimmune diseases, in some cases based on mechanistical observations. We herein discuss what we currently know and what we expect will come in the next future. Ultimately, epigenetic treatments already being used in oncology may soon prove beneficial also in autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)226-236
Number of pages11
JournalCellular and Molecular Immunology
Volume8
Issue number3
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Autoimmunity
Epigenomics
Autoimmune Diseases
Immune Tolerance
Monozygotic Twins
Genome-Wide Association Study
Gene Expression Regulation
DNA Methylation
Post Translational Protein Processing
Systemic Lupus Erythematosus
Histones
Multiple Sclerosis
Rheumatoid Arthritis
Theoretical Models
Therapeutics

Keywords

  • DNA methylation
  • histone modification
  • microRNA
  • tolerance breakdown

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology

Cite this

Meda, F., Folci, M., Baccarelli, A., & Selmi, C. (2011). The epigenetics of autoimmunity. Cellular and Molecular Immunology, 8(3), 226-236. https://doi.org/10.1038/cmi.2010.78

The epigenetics of autoimmunity. / Meda, Francesca; Folci, Marco; Baccarelli, Andrea; Selmi, Carlo.

In: Cellular and Molecular Immunology, Vol. 8, No. 3, 05.2011, p. 226-236.

Research output: Contribution to journalArticle

Meda, F, Folci, M, Baccarelli, A & Selmi, C 2011, 'The epigenetics of autoimmunity', Cellular and Molecular Immunology, vol. 8, no. 3, pp. 226-236. https://doi.org/10.1038/cmi.2010.78
Meda F, Folci M, Baccarelli A, Selmi C. The epigenetics of autoimmunity. Cellular and Molecular Immunology. 2011 May;8(3):226-236. https://doi.org/10.1038/cmi.2010.78
Meda, Francesca ; Folci, Marco ; Baccarelli, Andrea ; Selmi, Carlo. / The epigenetics of autoimmunity. In: Cellular and Molecular Immunology. 2011 ; Vol. 8, No. 3. pp. 226-236.
@article{eed0b35a186940dd82ad06e9e7361f59,
title = "The epigenetics of autoimmunity",
abstract = "The etiology of autoimmune diseases remains largely unknown. Concordance rates in monozygotic twins are lower than 50{\%} while genome-wide association studies propose numerous significant associations representing only a minority of patients. These lines of evidence strongly support other complementary mechanisms involved in the regulation of genes expression ultimately causing overt autoimmunity. Alterations in the post-translational modification of histones and DNA methylation are the two major epigenetic mechanisms that may potentially cause a breakdown of immune tolerance and the perpetuation of autoimmune diseases. In recent years, several studies both in clinical settings and experimental models proposed that the epigenome may hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically, data support the impact of epigenetic changes in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis and other autoimmune diseases, in some cases based on mechanistical observations. We herein discuss what we currently know and what we expect will come in the next future. Ultimately, epigenetic treatments already being used in oncology may soon prove beneficial also in autoimmune diseases.",
keywords = "DNA methylation, histone modification, microRNA, tolerance breakdown",
author = "Francesca Meda and Marco Folci and Andrea Baccarelli and Carlo Selmi",
year = "2011",
month = "5",
doi = "10.1038/cmi.2010.78",
language = "English (US)",
volume = "8",
pages = "226--236",
journal = "Cellular and Molecular Immunology",
issn = "1672-7681",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - The epigenetics of autoimmunity

AU - Meda, Francesca

AU - Folci, Marco

AU - Baccarelli, Andrea

AU - Selmi, Carlo

PY - 2011/5

Y1 - 2011/5

N2 - The etiology of autoimmune diseases remains largely unknown. Concordance rates in monozygotic twins are lower than 50% while genome-wide association studies propose numerous significant associations representing only a minority of patients. These lines of evidence strongly support other complementary mechanisms involved in the regulation of genes expression ultimately causing overt autoimmunity. Alterations in the post-translational modification of histones and DNA methylation are the two major epigenetic mechanisms that may potentially cause a breakdown of immune tolerance and the perpetuation of autoimmune diseases. In recent years, several studies both in clinical settings and experimental models proposed that the epigenome may hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically, data support the impact of epigenetic changes in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis and other autoimmune diseases, in some cases based on mechanistical observations. We herein discuss what we currently know and what we expect will come in the next future. Ultimately, epigenetic treatments already being used in oncology may soon prove beneficial also in autoimmune diseases.

AB - The etiology of autoimmune diseases remains largely unknown. Concordance rates in monozygotic twins are lower than 50% while genome-wide association studies propose numerous significant associations representing only a minority of patients. These lines of evidence strongly support other complementary mechanisms involved in the regulation of genes expression ultimately causing overt autoimmunity. Alterations in the post-translational modification of histones and DNA methylation are the two major epigenetic mechanisms that may potentially cause a breakdown of immune tolerance and the perpetuation of autoimmune diseases. In recent years, several studies both in clinical settings and experimental models proposed that the epigenome may hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically, data support the impact of epigenetic changes in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis and other autoimmune diseases, in some cases based on mechanistical observations. We herein discuss what we currently know and what we expect will come in the next future. Ultimately, epigenetic treatments already being used in oncology may soon prove beneficial also in autoimmune diseases.

KW - DNA methylation

KW - histone modification

KW - microRNA

KW - tolerance breakdown

UR - http://www.scopus.com/inward/record.url?scp=79955675794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955675794&partnerID=8YFLogxK

U2 - 10.1038/cmi.2010.78

DO - 10.1038/cmi.2010.78

M3 - Article

C2 - 21278766

AN - SCOPUS:79955675794

VL - 8

SP - 226

EP - 236

JO - Cellular and Molecular Immunology

JF - Cellular and Molecular Immunology

SN - 1672-7681

IS - 3

ER -